secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK:        0001725430
Form:       8-K
Filed at:   2024-02-02T23:59:59+00:00
Accession:  0001493152-24-004793
Event type: earnings
Sentiment:  positive
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INBS preliminary Q2 revenue $0.76M (+114% YoY); six-month revenue $1.56M (+337%)
--------------------------------------------------------------------------------

- Preliminary unaudited Q2 FY2024 revenue ~$0.76M, up 114% vs prior year quarter.
- Six-month revenue ~$1.56M, up 337% vs same period last year.
- Cartridge sales rose ~30% and reader sales rose ~91% for the six-month period.
- Growth driven by market expansion; New Zealand entry and planned Asia-Pacific push.
- Results are preliminary; full Q2 report expected in Form 10-Q filed week of Feb 5, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725430/000149315224004793/0001493152-24-004793-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725430/000149315224004793/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-004793

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer